-
AMP/ASCO/CAP Variant Guidelines Integrated into NGS variant interpretation
Nov 27, 2017, 15:26 PM by Michael CroftESPOO, FINLAND - Nov 27, 2017 - Finnish bioinformatics firm, Euformatics has released an improved version of its CE-marked omnomicsNGS software that incorporates the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerFull story -
Three IT Tracks At Tri-Con Dig Deep Into Cloud, Data Commons, FAIR Data
Nov 27, 2017, 12:55 PM by Michael CroftFull storyBio-IT World | The Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks coming from the conference we’ve marked so far.
-
Lexogen and Partek Deliver QuantSeq Analysis Solution
Nov 27, 2017, 12:43 PM by Michael CroftST. LOUIS AND VIENNA, MO, UNITED STATES AND GERMANY - Nov 28, 2017 - Partek and Lexogen scientists have joined forces to deliver an easy-to-use analysis pipeline in Partek® Flow® software for data generated by Lexogens QuantSeq 3 Library Prep KitsFull story -
Senator Calls For More Scrutiny Of Home DNA Test Industry
Nov 27, 2017, 09:10 AM by Michael CroftNBC News | With the holiday season in full swing, Sen. Chuck Schumer said customers may be putting their genetic information at risk of being sold to third parties.Full story -
Multiple Myeloma Data Analysis Shows Need For Diversity In Research
Nov 22, 2017, 15:50 PM by Michael CroftBio-IT World | An analysis of data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study by researchers from the Keck School of Medicine of the University of Southern California (USC) Department of Translational Genomics found significant genetic mutation differences between African Americans and Caucasians with multiple myeloma. African American patients showed increased mutations in genes previously unassociated with multiple myeloma. The findings were published today in PLoS Genetics.Full story -
Tackling The Internet Of Things In Healthcare
Nov 22, 2017, 08:15 AM by Michael CroftFull storyBio-IT World | Cambridge Healthtech Institute's Inaugural Healthcare Internet of Things event in San Francisco next February aims to bring together constituents and stakeholders to share cases studies and pilot programs that showcase the healthcare industry’s collaborative efforts toward the adoption and implementation of IoT. Here are a few of the talks we have flagged on our agendas.
-
Sensors Could Identify Biomarkers, Improve Early-Stage Detection, Treatment Of Diseases
Nov 21, 2017, 12:00 PM by Michael CroftFull storyBio-IT World Brief | Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections, and different medical conditions at early stages.
-
Creative Biolabs Launches Membrane Protein Antibody Discovery Service
Nov 20, 2017, 04:29 AM by Michael CroftSHIRLEY, NY - Nov 20, 2017 - Growing interest is focusing on the potential of membrane protein as a breaking point of antibody-based therapy and diagnosis for various diseasesFull story -
Gene Drives Aren’t Safe Enough To Trial Right Now
Nov 17, 2017, 13:50 PM by Michael CroftMIT Technology Review | Technology's answer to invasive species and disease-spreading insects is looking riskier than ever in its current form.Full story -
The Big Idea Behind Big Data
Nov 17, 2017, 11:14 AM by Michael CroftNPR.org | As we find our way in a world shaped by Big Data, it's not the reams of information we gather but the networks they illuminate that's the newest addition to science's index of things.Full story -
In Search For Alzheimer's Drugs, Researchers Must Go Beyond Beta Amyloid
Nov 17, 2017, 09:47 AM by Michael CroftSTAT | In the search for Alzheimer's drugs, it's time to pay more attention to drugs that go beyond targeting beta amyloid, a protein linked to the disease.Full story -
Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience
Nov 17, 2017, 04:33 AM by Michael Croft- Nov 17, 2017 - November 16, 2017, Oxford, England and San Francisco, Calif. - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNAFull story -
Creative Enzymes Released Newly-updated Products
Nov 16, 2017, 22:42 PM by Michael CroftSHIRLEY, NY - Nov 17, 2017 - November, 15th, 2017, as an experienced supplier and manufacturer in enzyme field in USA, Creative Enzymes adds three products belonging to hydrolases, food & beverage and oxidoreductases separatelyFull story -
MasterControl Launches Version 11.7, Provides Enhanced Analytics Capabilities and Robust Clinical and Regulatory Solutions
Nov 16, 2017, 13:20 PM by Michael CroftSALT LAKE CITY, UT, UNITED STATES - Nov 16, 2017 - MasterControl Inc., a leading global provider of software solutions that enable life science and other regulated companies to deliver life-improving products to more people sooner, today announced it has released MasterControl Version 11Full story -
WIRB-Copernicus Group Partners with Veeva Systems Inc.
Nov 16, 2017, 08:19 AM by Michael CroftPRINCETON, NJ - Nov 16, 2017 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems IncFull story -
Drug Development: Making the impossible possible
Nov 16, 2017, 04:34 AM by Michael Croft- Nov 16, 2017 - THE Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural eventFull story -
African scientists get their own open-access publishing platform
Nov 15, 2017, 12:55 PM by Michael CroftNature News & Comment | Venture will launch next year and seeks to strengthen continent's science by helping academics share work more quickly.Full story -
US Scientists Try 1st Gene Editing In The Body
Nov 15, 2017, 11:08 AM by Michael CroftAP News | Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease.Full story -
Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx And Expanded Use Of MiSeqDx
Nov 15, 2017, 10:35 AM by Michael CroftBio-IT World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.Full story -
Immuno-oncology CRO secures Macrophage Pharma agreement
Nov 15, 2017, 06:30 AM by Michael Croft- Nov 10, 2017 - Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma LtdFull story